过去一年中添加的文章,按日期排序
Increased plasma imatinib exposure and toxicity in chronically treated GIST patients with SARS-CoV-2 infection: a case series
S Gagno, B Posocco, O Marco, C Eleonora… - Frontiers in … - frontiersin.org
4 天前 - … severe coronavirus disease-19 caused by acute respiratory syndrome coronavirus
2 (… drug monitoring (TDM) and pharmacogenetic (PGx) analyses of polymorphisms in genes …
2 (… drug monitoring (TDM) and pharmacogenetic (PGx) analyses of polymorphisms in genes …
High Burden of Ileus and Pneumonia in Clozapine-Treated Individuals With Schizophrenia: A Finnish 25-Year Follow-Up Register Study
JJ Partanen, P Häppölä, A Kämpe… - American Journal of …, 2024 - psychiatryonline.org
15 天前 - … Pharmacogenetics Implementation Consortium guidelines (44). We investigated
pharmacogenetic … ) using the same covariates as in the above pharmacogenetic analyses. The …
pharmacogenetic … ) using the same covariates as in the above pharmacogenetic analyses. The …
Adverse Drug Reactions in Children with Congenital Heart Disease: A Scoping Review
E Toni, H Ayatollahi, R Abbaszadeh… - Pediatric Drugs, 2024 - Springer
59 天前 - … of drug therapy in adults with cardiovascular diseases, and their adverse drug reactions
(… Further research is essential for optimizing dosing, pharmacogenetics, and alternative …
(… Further research is essential for optimizing dosing, pharmacogenetics, and alternative …
[HTML][HTML] ADRB2 and ADCY9 Sequence Variations in Brazilian Asthmatic Patients
VC Silva, RLF Teixeira, RE do Livramento… - Current Issues in …, 2024 - mdpi.com
79 天前 - … Asthma is a chronic inflammatory disease of the respiratory tract that affects … within
the ADRB2 and ADCY9 genes of pharmacogenetic interest for the treatment of asthma. The …
the ADRB2 and ADCY9 genes of pharmacogenetic interest for the treatment of asthma. The …
The laterodorsal tegmental nucleus improves breathing and sleep in a Parkinson's disease animal model
N Miranda, L Oliveira, T Moreira, F Kalume… - …, 2024 - journals.physiology.org
123 天前 - … Selective pharmacogenetic stimulation of ChAT + neurons of the LDTg rescued the
respiratory frequency during REMs and reduced the number of apneas both in NREMs and …
respiratory frequency during REMs and reduced the number of apneas both in NREMs and …
… and GLCCΙ1 gene polymorphisms with clinical phenotype, disease progression, and response to glucocorticoid treatment in chronic obstructive pulmonary disease
C Ntenti - 2024 - didaktorika.gr
126 天前 - This doctoral thesis investigates the genetic underpinnings of Chronic Obstructive
Pulmonary Disease (COPD) progression and the differential response to treatment, focusing …
Pulmonary Disease (COPD) progression and the differential response to treatment, focusing …
Genetic, Epigenetic, Environmental, and Pharmacological Models for Neuroscience, Neurologic Diseases, and Psychiatric Disorders: Advancement in Bench-to …
M Tanaka - 2024 - mdpi.com
159 天前 - The Special Issue," Genetic, Epigenetic, Environmental, and Pharmacological
Models for Neuroscience, Neurologic Diseases, and Psychiatric Disorders: Advancement in …
Models for Neuroscience, Neurologic Diseases, and Psychiatric Disorders: Advancement in …
All Around Suboptimal Health
W Wang - Springer
167 天前 - … , chronic respiratory diseases, cancer and dental pathologies. The cost-effective …
or drugdisease interactions relying on emerging technologies, such as pharmacogenetics, …
or drugdisease interactions relying on emerging technologies, such as pharmacogenetics, …
Idiopathic Pulmonary Fibrosis: From Common Microscopy to Single-Cell Biology and Precision Medicine
234 天前 - … lung disease of unknown etiology and is included in the large, complex, and
heterogeneous group of interstitial lung diseases (… are ongoing in the area of pharmacogenetics. …
heterogeneous group of interstitial lung diseases (… are ongoing in the area of pharmacogenetics. …
Reply: Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease
263 天前 - … pharmacogenetic interaction between telomere shortening and immunosuppression
leading to harm in patients with non-idiopathic pulmonary fibrosis interstitial lung disease (…
leading to harm in patients with non-idiopathic pulmonary fibrosis interstitial lung disease (…